|
|
| BC | supplementation |
| placebo |
|
|
|
|
| Baseline | 4 months | d | Baseline | 4 months | d |
| T-score LS | Normal | 0.5 ± 1.3 | 0.5 ± 1.1 | 0.01 | −0.5 ± 0.6 | −0.4 ± 0.7 | 0.16 |
|
| Osteopenia | −1.4 ± 0.7 | −1.5 ± 0.6 | 0.15 | −1.4 ± 0.7 | −1.1 ± 0.8a | 0.40 |
|
| Osteporosis | −1.9 ± 0.9 | −1.8 ± 0.8 | 0.16 | −2.1 ± 0.7 | −2.1 ± 0.6 | 0.03 |
| T-score FN | Normal | −0.3 ± 0.9 | −0.4 ± 1.0 | 0.03 | −0.4 ± 0.7 | −0.4 ± 0.7 | 0.00 |
|
| Osteopenia | −1.0 ± 0.9 | −1.1 ± 0.8 | 0.16 | −0.8 ± 0.9 | −0.7 ± 0.9 | 0.09 |
|
| Osteporosis | −1.7 ± 0.7 | −1.8 ± 0.9 | 0.13 | −1.5 ± 0.7 | −1.5 ± 0.5 | 0.04 |
| T-score Arm | Normal | −0.2 ± 0.6 | −0.2 ± 0.7 | 0.00 | −0.1 ± 0.7 | −0.3 ± 0.6 | 0.23 |
|
| Osteopenia | −1.1 ± 0.6 | −1.0 ± 0.6 | 0.17 | −0.9 ± 0.7 | −1.0 ± 1.1 | 0.12 |
|
| Osteporosis | −1.7 ± 1.9 | −1.4 ± 1.4 | 0.14 | −1.9 ± 3.1 | −2.5 ± 0.7 | 0.24 |